Retraction notice to "BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma" [Biochem. Biophys. Res. Commun. 491 (2017) 939-945]

Biochem Biophys Res Commun. 2018 Mar 18;497(4):1184. doi: 10.1016/j.bbrc.2018.03.006.

Authors

Jin Li¹, Changgeng Qian², Qianqian Zhou¹, Jiwei Li¹, Kunlun Li¹, Pingyong Yi¹

Affiliations

¹ Department of Hematology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, 410006, China.
² Guangzhou BeBetter Medicine Technology Co., Ltd, Guangzhou, Guangdong, 510000, China.

PMID: 29530244
DOI: 10.1016/j.bbrc.2018.03.006

No abstract available

Publication types

Retraction Notice